Eli Lilly and Company (LLY)
USD 818.02
(-2.61%)
USD 818.02
(-2.61%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 5.24 Billion USD | -16.08% |
| 2022 | 6.24 Billion USD | 11.88% |
| 2021 | 5.58 Billion USD | -9.88% |
| 2020 | 6.19 Billion USD | 33.55% |
| 2019 | 4.63 Billion USD | 43.5% |
| 2018 | 3.23 Billion USD | 1683.54% |
| 2017 | -204.1 Million USD | -107.46% |
| 2016 | 2.73 Billion USD | 13.67% |
| 2015 | 2.4 Billion USD | 0.75% |
| 2014 | 2.39 Billion USD | -48.97% |
| 2013 | 4.68 Billion USD | 14.58% |
| 2012 | 4.08 Billion USD | -5.96% |
| 2011 | 4.34 Billion USD | -14.24% |
| 2010 | 5.06 Billion USD | 17.11% |
| 2009 | 4.32 Billion USD | 308.93% |
| 2008 | -2.07 Billion USD | -170.16% |
| 2007 | 2.95 Billion USD | 10.9% |
| 2006 | 2.66 Billion USD | 34.51% |
| 2005 | 1.97 Billion USD | 9.36% |
| 2004 | 1.81 Billion USD | -29.32% |
| 2003 | 2.56 Billion USD | -5.43% |
| 2002 | 2.7 Billion USD | -2.59% |
| 2001 | 2.78 Billion USD | -9.08% |
| 2000 | 3.05 Billion USD | 12.38% |
| 1999 | 2.72 Billion USD | 29.7% |
| 1998 | 2.09 Billion USD | 644.77% |
| 1997 | -385.1 Million USD | -125.28% |
| 1996 | 1.52 Billion USD | -33.5% |
| 1995 | 2.29 Billion USD | 78.13% |
| 1994 | 1.28 Billion USD | 167.83% |
| 1993 | 480.2 Million USD | -32.24% |
| 1992 | 708.7 Million USD | -46.09% |
| 1991 | 1.31 Billion USD | 16.62% |
| 1990 | 1.12 Billion USD | 19.99% |
| 1989 | 939.5 Million USD | 23.46% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 970.3 Million USD | -67.3% |
| 2024 Q2 | 2.96 Billion USD | 32.28% |
| 2024 Q1 | 2.24 Billion USD | 2.43% |
| 2023 Q1 | 1.34 Billion USD | -30.59% |
| 2023 Q2 | 1.76 Billion USD | 31.1% |
| 2023 FY | 5.24 Billion USD | -16.08% |
| 2023 Q3 | -57.4 Million USD | -103.26% |
| 2023 Q4 | 2.18 Billion USD | 3914.81% |
| 2022 FY | 6.24 Billion USD | 11.88% |
| 2022 Q3 | 1.45 Billion USD | 52.41% |
| 2022 Q4 | 1.93 Billion USD | 33.48% |
| 2022 Q1 | 1.9 Billion USD | 10.24% |
| 2022 Q2 | 952.5 Million USD | -49.94% |
| 2021 Q2 | 1.39 Billion USD | 2.58% |
| 2021 Q3 | 1.11 Billion USD | -20.15% |
| 2021 Q4 | 1.72 Billion USD | 55.49% |
| 2021 FY | 5.58 Billion USD | -9.88% |
| 2021 Q1 | 1.35 Billion USD | -35.97% |
| 2020 Q4 | 2.11 Billion USD | 75.17% |
| 2020 Q1 | 1.45 Billion USD | -2.62% |
| 2020 Q2 | 1.41 Billion USD | -3.06% |
| 2020 FY | 6.19 Billion USD | 33.55% |
| 2020 Q3 | 1.2 Billion USD | -14.42% |
| 2019 Q4 | 1.49 Billion USD | 19.28% |
| 2019 Q1 | 4.24 Billion USD | 277.0% |
| 2019 Q2 | 1.32 Billion USD | -68.71% |
| 2019 FY | 4.63 Billion USD | 43.5% |
| 2019 Q3 | 1.25 Billion USD | -5.52% |
| 2018 FY | 3.23 Billion USD | 1683.54% |
| 2018 Q2 | -259.9 Million USD | -121.35% |
| 2018 Q3 | 1.14 Billion USD | 542.29% |
| 2018 Q1 | 1.21 Billion USD | 173.47% |
| 2018 Q4 | 1.12 Billion USD | -2.12% |
| 2017 Q2 | 1 Billion USD | 1009.75% |
| 2017 Q4 | -1.65 Billion USD | -398.22% |
| 2017 FY | -204.1 Million USD | -107.46% |
| 2017 Q1 | -110.8 Million USD | -114.36% |
| 2017 Q3 | 555.6 Million USD | -44.88% |
| 2016 Q4 | 771.8 Million USD | -0.8% |
| 2016 Q2 | 747.7 Million USD | 69.89% |
| 2016 Q3 | 778 Million USD | 4.05% |
| 2016 FY | 2.73 Billion USD | 13.67% |
| 2016 Q1 | 440.1 Million USD | -8.01% |
| 2015 Q4 | 478.4 Million USD | -40.18% |
| 2015 FY | 2.4 Billion USD | 0.75% |
| 2015 Q1 | 529.5 Million USD | 23.57% |
| 2015 Q2 | 600.8 Million USD | 13.47% |
| 2015 Q3 | 799.7 Million USD | 33.11% |
| 2014 Q2 | 733.5 Million USD | 0.77% |
| 2014 FY | 2.39 Billion USD | -48.97% |
| 2014 Q1 | 727.9 Million USD | 0.05% |
| 2014 Q3 | 500.6 Million USD | -31.75% |
| 2014 Q4 | 428.5 Million USD | -14.4% |
| 2013 Q3 | 1.2 Billion USD | -0.26% |
| 2013 Q4 | 727.5 Million USD | -39.53% |
| 2013 FY | 4.68 Billion USD | 14.58% |
| 2013 Q1 | 1.54 Billion USD | 87.14% |
| 2013 Q2 | 1.2 Billion USD | -22.08% |
| 2012 Q2 | 923.6 Million USD | -8.65% |
| 2012 Q4 | 827.2 Million USD | -37.65% |
| 2012 Q3 | 1.32 Billion USD | 43.63% |
| 2012 Q1 | 1.01 Billion USD | 17.82% |
| 2012 FY | 4.08 Billion USD | -5.96% |
| 2011 Q1 | 1.05 Billion USD | -9.72% |
| 2011 Q3 | 1.23 Billion USD | 3.26% |
| 2011 Q4 | 858.2 Million USD | -30.58% |
| 2011 Q2 | 1.19 Billion USD | 13.39% |
| 2011 FY | 4.34 Billion USD | -14.24% |
| 2010 FY | 5.06 Billion USD | 17.11% |
| 2010 Q3 | 1.3 Billion USD | -3.41% |
| 2010 Q4 | 1.16 Billion USD | -10.23% |
| 2010 Q1 | 1.24 Billion USD | 36.34% |
| 2010 Q2 | 1.34 Billion USD | 8.08% |
| 2009 Q4 | 915.4 Million USD | -2.8% |
| 2009 Q2 | 1.15 Billion USD | -11.77% |
| 2009 Q3 | 941.8 Million USD | -18.71% |
| 2009 Q1 | 1.31 Billion USD | 136.18% |
| 2009 FY | 4.32 Billion USD | 308.93% |
| 2008 Q1 | 1.06 Billion USD | 24.57% |
| 2008 Q3 | -465.6 Million USD | -148.56% |
| 2008 Q2 | 958.8 Million USD | -9.91% |
| 2008 Q4 | -3.62 Billion USD | -679.51% |
| 2008 FY | -2.07 Billion USD | -170.16% |
| 2007 Q4 | 854.4 Million USD | -7.76% |
| 2007 FY | 2.95 Billion USD | 10.9% |
| 2007 Q1 | 508.7 Million USD | 284.5% |
| 2007 Q2 | 663.6 Million USD | 30.45% |
| 2007 Q3 | 926.3 Million USD | 39.59% |
| 2006 FY | 2.66 Billion USD | 34.51% |
| 2006 Q4 | 132.3 Million USD | -84.86% |
| 2006 Q3 | 873.6 Million USD | 6.28% |
| 2006 Q2 | 822 Million USD | -1.53% |
| 2006 Q1 | 834.8 Million USD | 19.16% |
| 2005 Q2 | -252 Million USD | -134.21% |
| 2005 Q3 | 794.4 Million USD | 415.24% |
| 2005 Q4 | 700.6 Million USD | -11.81% |
| 2005 FY | 1.97 Billion USD | 9.36% |
| 2005 Q1 | 736.6 Million USD | 30791.67% |
| 2004 Q1 | 400.4 Million USD | -46.41% |
| 2004 Q3 | 755.2 Million USD | 14.96% |
| 2004 Q4 | -2.4 Million USD | -100.32% |
| 2004 FY | 1.81 Billion USD | -29.32% |
| 2004 Q2 | 656.9 Million USD | 64.06% |
| 2003 Q2 | 692.2 Million USD | 70.07% |
| 2003 Q1 | 407 Million USD | -44.72% |
| 2003 Q3 | 714.4 Million USD | 3.21% |
| 2003 Q4 | 747.2 Million USD | 4.59% |
| 2003 FY | 2.56 Billion USD | -5.43% |
| 2002 Q1 | 629.2 Million USD | 9.35% |
| 2002 Q4 | 736.3 Million USD | 7.66% |
| 2002 Q3 | 683.9 Million USD | 3.86% |
| 2002 FY | 2.7 Billion USD | -2.59% |
| 2002 Q2 | 658.5 Million USD | 4.66% |
| 2001 Q1 | 806.8 Million USD | 5.15% |
| 2001 Q4 | 575.4 Million USD | 0.93% |
| 2001 FY | 2.78 Billion USD | -9.08% |
| 2001 Q3 | 570.1 Million USD | -31.12% |
| 2001 Q2 | 827.7 Million USD | 2.59% |
| 2000 Q3 | 778.8 Million USD | 16.9% |
| 2000 Q1 | 845.5 Million USD | 7.53% |
| 2000 FY | 3.05 Billion USD | 12.38% |
| 2000 Q2 | 666.2 Million USD | -21.21% |
| 2000 Q4 | 767.3 Million USD | -1.48% |
| 1999 Q1 | 625.7 Million USD | 10.29% |
| 1999 Q3 | 732.6 Million USD | 27.1% |
| 1999 Q4 | 786.3 Million USD | 7.33% |
| 1999 FY | 2.72 Billion USD | 29.7% |
| 1999 Q2 | 576.4 Million USD | -7.88% |
| 1998 Q4 | 567.3 Million USD | 9.48% |
| 1998 Q3 | 518.2 Million USD | 5.48% |
| 1998 Q2 | 491.3 Million USD | -5.72% |
| 1998 Q1 | 521.1 Million USD | 13.9% |
| 1998 FY | 2.09 Billion USD | 644.77% |
| 1997 Q4 | 457.5 Million USD | 0.13% |
| 1997 Q1 | 432.6 Million USD | 15.98% |
| 1997 Q2 | -1.73 Billion USD | -500.39% |
| 1997 Q3 | 456.9 Million USD | 126.38% |
| 1997 FY | -385.1 Million USD | -125.28% |
| 1996 Q3 | 415.6 Million USD | 20.22% |
| 1996 Q4 | 373 Million USD | -10.25% |
| 1996 FY | 1.52 Billion USD | -33.5% |
| 1996 Q1 | 389.2 Million USD | 13.6% |
| 1996 Q2 | 345.7 Million USD | -11.18% |
| 1995 Q4 | 342.6 Million USD | -72.1% |
| 1995 FY | 2.29 Billion USD | 78.13% |
| 1995 Q3 | 1.22 Billion USD | 275.42% |
| 1995 Q2 | 327.1 Million USD | -16.81% |
| 1995 Q1 | 393.2 Million USD | 35.54% |
| 1994 Q4 | 290.1 Million USD | -8.97% |
| 1994 Q1 | 330.7 Million USD | 163.16% |
| 1994 FY | 1.28 Billion USD | 167.83% |
| 1994 Q2 | 346.6 Million USD | 4.81% |
| 1994 Q3 | 318.7 Million USD | -8.05% |
| 1993 Q3 | 294.4 Million USD | -15.11% |
| 1993 Q2 | 346.8 Million USD | -4.36% |
| 1993 Q1 | 362.6 Million USD | 16.52% |
| 1993 FY | 480.2 Million USD | -32.24% |
| 1993 Q4 | -523.6 Million USD | -277.85% |
| 1992 Q1 | 442.6 Million USD | 42.27% |
| 1992 Q3 | -268.5 Million USD | -179.39% |
| 1992 Q2 | 338.2 Million USD | -23.59% |
| 1992 FY | 708.7 Million USD | -46.09% |
| 1992 Q4 | 311.2 Million USD | 215.9% |
| 1991 FY | 1.31 Billion USD | 16.62% |
| 1991 Q3 | 297.5 Million USD | -6.3% |
| 1991 Q2 | 317.5 Million USD | -18.3% |
| 1991 Q4 | 311.1 Million USD | 4.57% |
| 1991 Q1 | 388.6 Million USD | 52.21% |
| 1990 FY | 1.12 Billion USD | 19.99% |
| 1990 Q2 | 274.4 Million USD | -19.48% |
| 1990 Q4 | 255.3 Million USD | -0.58% |
| 1990 Q1 | 340.8 Million USD | 51.26% |
| 1990 Q3 | 256.8 Million USD | -6.41% |
| 1989 FY | 939.5 Million USD | 23.46% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q3 | 212.4 Million USD | -2.16% |
| 1989 Q2 | 217.1 Million USD | 0.0% |
| 1989 Q4 | 225.3 Million USD | 6.07% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbbVie Inc. | 4.86 Billion USD | -7.761% |
| Bristol-Myers Squibb Company | 8.02 Billion USD | 34.699% |
| Bristol-Myers Squibb Company Ce | 8.02 Billion USD | 34.699% |
| Johnson & Johnson | 35.15 Billion USD | 85.093% |
| Merck & Co., Inc. | 365 Million USD | -1335.726% |
| Novartis AG | 14.85 Billion USD | 64.711% |
| Organon & Co. | 1.02 Billion USD | -412.258% |
| Pfizer Inc. | 2.11 Billion USD | -147.305% |